European Respiratory Society clinical practice guideline for the management of adult bronchiectasis
European Respiratory Journal · 2025-12 · 66 (6) · 2501126
DOI: 10.1183/13993003.01126-2025 ↗Kurz gefasst
Leitlinie in der Zeitschrift European Respiratory Journal, online erschienen am 28.09.2025. Verfasst von James D Chalmers und 29 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK jchalmers@dundee.ac.uk. Hauptthemen laut MEDLINE: Bronchiectasis, Pulmonary Medicine. Die Arbeit wurde bisher 181-mal zitiert (Crossref) und nennt 164 Literaturangaben. Gefördert von: European Respiratory Society, EMBARC.
Abstract (Originalsprache)
Background
Bronchiectasis is a common lung condition associated with wide range of infectious, immunological, autoimmune, allergic and genetic conditions. Exacerbations and daily symptoms have the largest impact on patients and healthcare systems, and they are the key focus of treatments. Current practice is heterogeneous globally, and bronchiectasis has historically been a neglected disease. Here, we present evidence-based international guidelines for the management of adults with bronchiectasis.
Methods
A European Respiratory Society (ERS) Task Force, comprising global experts, a methodologist and patient representatives, developed clinical practice guidelines in accordance with ERS methodology and the GRADE (Grading of Recommendations, Assessment, Development and Evaluations) approach. Systematic literature searches, data extraction and meta-analysis were performed to generate evidence tables, and recommendations were formulated using the evidence-to-decision framework. A total of eight PICO (Patients, Intervention, Comparator, Outcomes) questions and three narrative questions were developed. Recommendations The Task Force recommendations include strong recommendations in favour of airway clearance techniques for most patients with bronchiectasis, and pulmonary rehabilitation for those with impaired exercise capacity. We issue a strong recommendation for the use of long-term macrolide treatment for patients at high risk of exacerbations and a strong recommendation in favour of long-term inhaled antibiotics in patients with chronic Pseudomonas aeruginosa infection at high risk of exacerbation. Conditional recommendations support the use of eradication treatment or mucoactive drugs in specific circumstances. We suggest not to routinely use long-term oral, non-macrolide antibiotic treatment or inhaled corticosteroids. Additional guidance is also provided on testing for underlying causes, managing exacerbations and managing the deteriorating patient.
Conclusion
The ERS bronchiectasis guidelines provide an evidence-based framework for optimal management of adults with bronchiectasis and serve as a benchmark for evaluating the quality of care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK jchalmers@dundee.ac.uk.
- Task Force co-chairs.
- Royal Papworth Hospital NHS Foundation Trust and University of Cambridge, Cambridge, UK.
- Medical University of South Carolina, Charleston, SC, USA.
- School of Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
- Department of Respiratory Medicine and French Cystic Fibrosis National Reference Center, Hôpital Cochin, AP-HP and Université Paris Cité, Inserm U1016, Institut Cochin, Paris, France.
ORCID-Profile: James D Chalmers, Pierre-Régis Burgel, Francesco Blasi, Beatriz Herrero-Cortina, Sanjay H Chotirmall, Felix C Ringshausen, Lucy Morgan, Mattia Nigro, Thomy Tonia, Natalie Lorent, Pieter Goeminne, Michal Shteinberg, Stefano Aliberti
Förderung
- European Respiratory Society
- EMBARC
Zitieren
APA
Chalmers, J. D., Haworth, C. S., Flume, P., Long, M. B., Burgel, P. R., Dimakou, K., Blasi, F., Herrero-Cortina, B., Dhar, R., Chotirmall, S. H., Ringshausen, F. C., Altenburg, J., Morgan, L., Nigro, M., Crichton, M. L., Van Meel, C., Sibila, O., Timothy, A., Kompatsiari, E., …, & Aliberti, S. (2025). European Respiratory Society clinical practice guideline for the management of adult bronchiectasis. European Respiratory Journal, 66(6), 2501126. https://doi.org/10.1183/13993003.01126-2025
Vancouver
Chalmers JD, Haworth CS, Flume P, Long MB, Burgel PR, Dimakou K, et al. European Respiratory Society clinical practice guideline for the management of adult bronchiectasis. European Respiratory Journal. 2025;66(6):2501126. doi:10.1183/13993003.01126-2025
BibTeX
@article{Chalmers2025,
author = {Chalmers, James D and Haworth, Charles S and Flume, Patrick and Long, Merete B and Burgel, Pierre-Régis and Dimakou, Katerina and Blasi, Francesco and Herrero-Cortina, Beatriz and Dhar, Raja and Chotirmall, Sanjay H and Ringshausen, Felix C and Altenburg, Josje and Morgan, Lucy and Nigro, Mattia and Crichton, Megan L and Van Meel, Chayenne and Sibila, Oriol and Timothy, Alan and Kompatsiari, Eliza and Hedberg, Tanja and Vandendriessche, Thomas and McShane, Pamela J and Tonia, Thomy and Winthrop, Kevin and Loebinger, Michael R and Lorent, Natalie and Goeminne, Pieter and Shteinberg, Michal and Polverino, Eva and Aliberti, Stefano},
title = {European Respiratory Society clinical practice guideline for the management of adult bronchiectasis},
journal = {European Respiratory Journal},
year = {2025},
volume = {66},
number = {6},
pages = {2501126},
doi = {10.1183/13993003.01126-2025}
}
EUVIMED